These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16859874

  • 1. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
    Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, Lee MC, Kim SE.
    Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation of Glut-1 glucose transporter expression with.
    Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I.
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hiyoshi Y, Watanabe M, Imamura Y, Nagai Y, Baba Y, Yoshida N, Toyama E, Hayashi N, Baba H.
    Oncology; 2009 Dec; 76(4):286-92. PubMed ID: 19262068
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
    Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
    J Nucl Med; 2001 Oct; 42(10):1551-5. PubMed ID: 11585872
    [Abstract] [Full Text] [Related]

  • 11. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
    Nguyen XC, Lee WW, Chung JH, Park SY, Sung SW, Kim YK, So Y, Lee DS, Chung JK, Lee MC, Kim SE.
    Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
    [Abstract] [Full Text] [Related]

  • 12. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer.
    Kim YH, Choi JY, Do IG, Kim S, Kim BT.
    J Comput Assist Tomogr; 2013 Aug; 37(5):815-9. PubMed ID: 24045262
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
    Chung JH, Cho KJ, Lee SS, Baek HJ, Park JH, Cheon GJ, Choi CW, Lim SM.
    J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
    [Abstract] [Full Text] [Related]

  • 15. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG, Lee JH, Lee WA, Han KM.
    Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
    [Abstract] [Full Text] [Related]

  • 16. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
    Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.
    Clin Cancer Res; 2007 Nov 01; 13(21):6369-78. PubMed ID: 17975149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
    Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ.
    Int J Gynecol Cancer; 2012 May 01; 22(4):654-8. PubMed ID: 22398711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.